-
Entity
-
Individual
-
Location
-
C/O Zentalis Pharmaceuticals, Inc., 530 Seventh Avenue, Suite 2201, New York, NY
-
Summary
-
The estimated net worth of Dimitris Voliotis is at least $1.32M dollars as of February 14, 2022. Dimitris Voliotis is the SVP, Clinical Development of Zentalis Pharmaceuticals, Inc. and owns shares of Zentalis Pharmaceuticals, Inc. (ZNTL) stock worth about $1.32M.